Crossref
Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment
Biomedical Engineering Communications · 2022
DOI: 10.53388/bmec2022006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2022. Verfasst von YuTing Ji und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ji, Y., & Yang, H. (2022). Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment. Biomedical Engineering Communications. https://doi.org/10.53388/bmec2022006
Vancouver
Ji Y, Yang H. Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment. Biomedical Engineering Communications. 2022. doi:10.53388/bmec2022006
BibTeX
@article{Ji2022,
author = {Ji, YuTing and Yang, Hong},
title = {Genetically engineered cell membrane enhances nanodrug targeting capability to the inflamed lungs for effective treatment},
journal = {Biomedical Engineering Communications},
year = {2022},
doi = {10.53388/bmec2022006}
}
EUVIMED